Unknown

Dataset Information

0

Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.


ABSTRACT: Large-scale genetic aberrations that underpin prostate cancer development and progression, such as copy-number alterations (CNAs), have been described but the consequences of specific changes in many identified loci is limited. Germline SNPs in the 3q26.31 locus are associated with aggressive prostate cancer, and is the location of NAALADL2, a gene overexpressed in aggressive disease. The closest gene to NAALADL2 is TBL1XR1, which is implicated in tumour development and progression. Using publicly-available cancer genomic data we report that NAALADL2 and TBL1XR1 gains/amplifications are more prevalent in aggressive sub-types of prostate cancer when compared to primary cohorts. In primary disease, gains/amplifications occurred in 15.99% (95% CI: 13.02-18.95) and 14.96% (95% CI: 12.08-17.84%) for NAALADL2 and TBL1XR1 respectively, increasing in frequency in higher Gleason grade and stage tumours. Gains/amplifications result in transcriptional changes and the development of a pro-proliferative and aggressive phenotype. These results support a pivotal role for copy-number gains in this genetic region.

SUBMITTER: Simpson BS 

PROVIDER: S-EPMC7429505 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.

Simpson Benjamin S BS   Camacho Niedzica N   Luxton Hayley J HJ   Pye Hayley H   Finn Ron R   Heavey Susan S   Pitt Jason J   Moore Caroline M CM   Whitaker Hayley C HC  

Communications biology 20200814 1


Large-scale genetic aberrations that underpin prostate cancer development and progression, such as copy-number alterations (CNAs), have been described but the consequences of specific changes in many identified loci is limited. Germline SNPs in the 3q26.31 locus are associated with aggressive prostate cancer, and is the location of NAALADL2, a gene overexpressed in aggressive disease. The closest gene to NAALADL2 is TBL1XR1, which is implicated in tumour development and progression. Using public  ...[more]

Similar Datasets

| S-EPMC6091222 | biostudies-literature
| S-EPMC6296060 | biostudies-literature
| S-EPMC6872669 | biostudies-literature
| S-EPMC2836698 | biostudies-literature
| S-EPMC8167119 | biostudies-literature
| S-EPMC5754837 | biostudies-literature
| S-EPMC3142177 | biostudies-literature